Due to the retrospective nature of our study we could not analyze anemia and its management in detail because different thresholds for ribavirin dose reduction, transfusion or use of erythropoietin were applied by different physicians, preventing statistical comparisons. This evidence concerns the gene EPO and anemia (phenotype).